The GCC percutaneous coronary intervention market growth is charting an impressive trajectory as the convergence of pharmacology and interventional cardiology creates novel opportunities for locally developed and manufactured pharmaceutical adjuncts that enhance PCI outcomes and reduce complications. Antiplatelet therapies, anticoagulants, and contrast agents represent critical...